BackPharmaCyte Biotech Overview

PharmaCyte Biotech Research & Development

Research & Development expenses for PMCB.

Quarterly R&D Expenses

$93113.00
↓ 21.22% YoY

As of Jan 31, 2026

Annual R&D Expenses (TTM)

$456089.00
↑ 12.37% YoY

Trailing 12 months ending Jan 31, 2026

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin